The department of Microbiology and Parasitology of the School of Medicine of the University of Navarra is aninter-faculty department that carries out a wide range of work professor, assistance and research. In the latter section, the department collaborates intensively with the Institute of Tropical Health.

From an academic point of view, it is subdivided into two teaching sections: Microbiology and Parasitology, both focused on integrated teaching in the different Degrees (Nursing; Biology; Biochemistry; Pharmacy; Nutrition; Medicine) and Postgraduate courses. 

The department has fully equipped and certified BSL-3 facilities for the handling of human pathogens under the strictest safety measures. 

The main lines of research of department are mainly in the context of pathogenic microorganisms (virulence, typing, detection, diagnosis, treatment, vaccine immunoprophylaxis and food safety). The members of department are co-inventors of 23 patents and maintain strong collaborations with biomedical and pharmaceutical companies.

The laboratory of Food and Water Microbiology(Microbiology and Food Safety area) is located at department . This laboratory is certificate in compliance with the Principles of Good Practices of laboratory (GLP) for the performance of antibiotic, fungicide, preservative and stability efficacy tests in the fields of human and veterinary medicines and cosmetic products. In addition, laboratory offers other analytical services for the agri-food, pharmaceutical, chemical and Materials industries (most of them according to ISO standardised methods), following the quality standards of rule ISO 17025. 

On the other hand, lecturers who are specialists in Clinical Microbiology also work in the Microbiology and Infectious Diseases Departments at the Pamplona and Madrid offices. Clínica Universidad de NavarraThe clinical research is carried out at the Pamplona and Madrid offices. The clinical research lines are developed within the Navarra Health Research Institute (IDISNA) in the areas of diagnosis and treatment of infections associated with biofilms, infections caused by respiratory viruses, infections in transplant patients, infections related to healthcare attendance , infections caused by multi-resistant microorganisms and development of new antimicrobials.